Coronary heart disease in women: update 2008

N K Wenger1, L J Shaw, V Vaccarino

  • 1Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. nwenger@emory.edu

Insights

Coronary heart disease (CHD) is a major cause of death in US women. Early detection and tailored management strategies are crucial for improving outcomes and reducing mortality in women with heart conditions.

Area of Science:

  • Cardiology
  • Women's Health
  • Preventive Medicine

Background:

  • Coronary heart disease (CHD) is the primary cause of mortality among US women, accounting for approximately 250,000 deaths annually.
  • Preventive heart-health behaviors and aggressive risk reduction are vital to decrease CHD-related disability and fatalities in women.
  • Angina is a common presentation of CHD in women, highlighting the importance of chest pain assessment and risk stratification.

Purpose of the Study:

  • To emphasize the critical role of evidence-based algorithms in guiding cardiovascular imaging for women with suspected myocardial ischemia.
  • To identify strategies for improving survival rates in women diagnosed with CHD.
  • To address the unique management needs of women with CHD, considering biological, treatment, and psychosocial factors.

Main Methods:

  • Utilizing a robust evidence-based algorithm to guide cardiovascular imaging techniques.
  • Evaluating women with suspected myocardial ischemia.
  • Assessing functional capacity, with <5 METs identified as a marker of worsened prognosis.

Main Results:

  • Restricted functional capacity (<5 METs) is a consistent indicator of a poorer prognosis in women with CHD.
  • Younger women exhibit significantly higher mortality rates than men post-myocardial infarction and coronary bypass surgery.
  • Comorbidity, risk factors, biological differences, treatment variations, and psychosocial elements contribute to worse outcomes in women.

Conclusions:

  • Tailored management strategies are essential to address the specific needs of women with CHD.
  • Early identification and intervention for women with suspected myocardial ischemia can improve survival.
  • Further research into biological and psychosocial factors is needed to optimize CHD care for women.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...